drugset / Trial / NCT01632527
Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this Phase I/II study is to investigate the safety and preliminary efficacy of unilateral subretinal transplantation of HuCNS-SC cells in subjects with geographic atrophy secondary to age-related macular degeneration.
Timeline
- Start
- 2012-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allogeneic Stem Cells | Cell therapy | 200000 cells | Other |
| Subject | Allogeneic Stem Cells | Cell therapy | 1e+06 cells | Other |